Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activityJun Xie(Wuhan University), Junjie Zhang(Wuhan University)Molecular Therapy — OncolyticsApril 28, 202310.1016/j.omto.2023.04.006Cited by 11SaveCiteExport RISWatch citationsRelated PapersPalmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production|PLoS Pathogens|2024|13Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses|mBio|2023|11Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases|PLoS Pathogens|2024|9